[1]邱运华,宋晓耘,杨剑锋,等.远红外贴联合补肾活血方治疗良性前列腺增生症疗效观察[J].西部中医药,2020,33(03):123-125.[doi:10.12174/j.issn.1004-6852.2020.03.35]
 QIU Yunhua,SONG Xiaoyun,YANG Jianfeng,et al.Clinical Observation on Far Infrared Patch Combined with Kidney-invigorating Blood-activating Prescription in the Treatment of Benign Prostatic Hyperplasia[J].Western Journal of Traditional Chinese Medicine,2020,33(03):123-125.[doi:10.12174/j.issn.1004-6852.2020.03.35]
点击复制

远红外贴联合补肾活血方治疗良性前列腺增生症疗效观察
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年03期
页码:
123-125
栏目:
报道·特色医疗
出版日期:
2020-03-15

文章信息/Info

Title:
Clinical Observation on Far Infrared Patch Combined with Kidney-invigorating Blood-activating Prescription in the Treatment of Benign Prostatic Hyperplasia
文章编号:
1004-6852(2020)03-0123-03
作者:
邱运华宋晓耘杨剑锋郑金州余奎周细秋
上海中医药大学附属龙华医院浦东分院普外科,上海 200120
Author(s):
QIU Yunhua SONG Xiaoyun YANG Jianfeng ZHENG Jinzhou YU Kui ZHOU Xiqiu△
Surgery Department, Pudong Branch, Longhua Hospital Shanghai University of TCM, Shanghai 200120, China
关键词:
前列腺增生良性生活质量外治法红外贴补肾活血方中医药临床疗效
Keywords:
prostatic hyperplasia benign quality of life external therapy far infrared patchkidney-invigorating blood-activating TCM clinical effects
分类号:
R245
DOI:
10.12174/j.issn.1004-6852.2020.03.35
摘要:
目的:观察远红外贴联合补肾活血方治疗良性前列腺增生症的临床疗效。方法:将良性前列腺增生症患者126例采用随机对照法随机分为试验组和对照组各63例,试验组远红外贴外敷联合补肾活血方口服治疗,对照组口服盐酸坦索罗辛缓释胶囊治疗,治疗12周后观察两组患者国际前列腺症状评分、生活质量评分、前列腺体积、最大尿流率、残余尿量变化情况。结果:治疗后两组患者国际前列腺症状评分、生活质量评分、最大尿流率、残余尿量均较治疗前下降(P<0.05),两组治疗后比较差异无统计学意义(P>0.05);试验组前列腺体积较治疗前减小(P<0.05),对照组治疗前后比较差异无统计学意义(P>0.05),两组治疗后比较差异有统计学意义(P<0.05)。结论:远红外贴联合补肾活血方治疗良性前列腺增生在减小前列腺体积方面疗效优于盐酸坦索罗辛缓释胶囊。
Abstract:
Objective: To observe clinical effects of far infrared patch joined with kidney-invigorating blood-activating prescription in the treatment of benign prostatic hyperplasia. Methods: By using randomized controlled trial (RCT), all 126 patients were randomized into the experiment group and the control group, 63 cases each group, the experiment group accepted far infrared patch for external application and oral administration of kidney-invigorating blood-activating prescription, and the control group took tamsulosin hydrochloride sustained release capsules orally, to observe international prostate symptom score, quality of life score, prostatic volume, maximum urinary flow rate and residual urine volume after treating for 12 weeks. Results: After treatment, international prostate symptom score, quality of life score, maximum urinary flow rate and residual urine volume reduced in both groups compared with before treating (P<0.05), the difference had no statistical meaning between both groups (P>0.05), prostatic volume of the experiment group reduced compared with before treating (P<0.05), the difference had no statistical meaning in the control group before and after treating(P>0.05), the difference had no statistical meaningbetween both groups after treating(P<0.05). Conclusion: Far infrared patch joined with kidney-invigorating blood-activating prescription in the treatment of benign prostatic hyperplasia is superior to only tamsulosin hydrochloride sustained release capsules.

相似文献/References:

[1]刘万彪.中西药物联合治疗老年良性前列腺增生症80例[J].西部中医药,2013,26(06):93.
 LIU Wanbiao.Combination of Western Medicine and Traditional Chinese Medicine for 80 Senile Patients with Benign Prostatic Hyperplasia[J].Western Journal of Traditional Chinese Medicine,2013,26(03):93.
[2]李晓斌.Epley手法治疗后半规管良性位置性眩晕68例[J].西部中医药,2015,28(12):102.

备注/Memo

备注/Memo:
收稿日期:2019-02-05作者简介:邱运华(1971—),男,主治医师。研究方向:泌尿外科疾病的中西医结合诊治。△通讯作者:周细秋(1970—),男,主任医师。研究方向:普外科常见病的中西医结合诊治。 
更新日期/Last Update: 2020-03-15